Chopas James George 4
4 · Apellis Pharmaceuticals, Inc. · Filed Sep 17, 2024
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Sale
Common Stock
2024-09-16$36.21/sh−192$6,952→ 38,141 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on 09/13/2024.